• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Instil Bio, Inc. (NQ: TIL )

    12.04 -0.41 (-3.29%)
    Streaming Delayed Price Updated: 10:34 AM EDT, Aug 2, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 6,917
    Open 12.96
    Bid (Size) 11.58 (1)
    Ask (Size) 12.05 (1)
    Prev. Close 12.45
    Today's Range 12.04 - 12.96
    52wk Range 6.070 - 13.95
    Shares Outstanding 3,290,884
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Instil Bio and ImmuneOnco Announce License and Collaboration Agreement for Development of IMM2510, a Potentially Best-in-Class PD-L1xVEGF Bispecific Antibody, and IMM27M, a Novel Next-Generation Anti-CTLA-4 Antibody
    From Instil Bio
    Via GlobeNewswire
    Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga

    Performance

    YTD
    +54.95%
    +54.95%
    1 Month
    +19.92%
    +19.92%
    3 Month
    +7.31%
    +7.31%
    6 Month
    +2.47%
    +2.47%
    1 Year
    +9.85%
    +9.85%

    More News

    Read More
    TIL Stock Earnings: Instil Bio Beats EPS for Q4 2023
    Via InvestorPlace
    TIL Stock Earnings: Instil Bio Beats EPS for Q2 2023
    Via InvestorPlace
    Instil Bio Resumes ITIL-306 Study In Lung, Ovarian, Renal Cancers
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Via InvestorPlace
    TIL Stock Earnings: Instil Bio Misses EPS for Q1 2024
    Via InvestorPlace
    Instil Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
    From Instil Bio
    Via GlobeNewswire
    Instil Bio Announces Strategic Update
    From Instil Bio
    Via GlobeNewswire
    TIL Stock Earnings: Instil Bio Misses EPS for Q1 2023
    Via InvestorPlace
    TIL Stock Earnings: Instil Bio Misses EPS for Q3 2023
    Via InvestorPlace
    Instil Bio Announces Effective Date of 1-for-20 Reverse Stock Split
    From Instil Bio
    Via GlobeNewswire
    Instil Bio Reports Third Quarter 2023 Financial Results and Provides Corporate Update
    From Instil Bio
    Via GlobeNewswire
    Instil Bio Announces Poster Presentations of ITIL-306 Preclinical Data at SITC 2023 Annual Meeting
    From Instil Bio
    Via GlobeNewswire
    Instil Bio Reports Second Quarter 2023 Financial Results and Provides Corporate Update
    From Instil Bio
    Via GlobeNewswire
    Benzinga's Top Ratings Upgrades, Downgrades For June 29, 2023
    Via Benzinga
    Instil Bio Announces Oral Presentation of ITIL-306 Preclinical Data at British Society for Gene and Cell Therapy Annual Conference
    From Instil Bio
    Via GlobeNewswire
    Instil Bio Reports First Quarter 2023 Financial Results and Provides Corporate Update
    From Instil Bio
    Via GlobeNewswire
    Instil Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
    From Instil Bio
    Via GlobeNewswire
    NASDAQ:TIL Shareholder Notice: Investigation over Potential Wrongdoing at Instil Bio, Inc.
    Via SBWire
    Instil Bio Announces Extension of Cash Runway Beyond 2026 with the Consolidation of R&D Operations to its Manchester, U.K. Site
    From Instil Bio
    Via GlobeNewswire
    Instil Bio Announces Resumption of Clinical Trial of CoStAR-TIL Candidate ITIL-306 in Lung, Ovarian, and Renal Cancer
    From Instil Bio
    Via GlobeNewswire
    INSTIL BIO ALERT: Bragar Eagel & Squire, P.C. is Investigating Instil Bio, Inc. on Behalf of Instil Bio Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.